Positive results with SGLT2 inhibitor in patients with diabetic kidney disease across all levels of eGFR

3' education - Apr. 17, 2019

Educational information

This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.

Faculty

Prof Carol Pollock, MD, is a nephrologist and Professor of Medicine at the University of Sydney School of Medicine, Sydney, Australia

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the CREDENCE trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.